Jeremy is an epidemiologist and computer scientist with nearly 25 years of experience in the science and technology of big data.

Kevin Riley is a senior executive with 25+ years of healthcare and life sciences technology experience. He is a proven CEO and product leader, launching many businesses to market with competitive differentiation and authentic customer value.

Nicolle is an epidemiologist with 20 years of industry experience. She serves as a senior scientific voice ensuring appropriate and principled use of RWD and RWE, designing and communicating scientific frameworks, standards, and methodologies, and collaborating with stakeholders globally.

Richard is Chief Growth Officer to Aetion and has led business development for several health care technology companies serving the life sciences industry.

Sebastian is a physician and pharmacoepidemiologist with 25 years of experience in analyzing health care databases.

Wendy Turenne is a healthcare analytics specialist with over 20 years of experience building bridges between data, analytics and business strategy.

David is Chief Business Officer to Aetion, responsible for leading enterprisewide initiatives and operations that accelerate Aetion’s growth and efficiency.

Ken Watson is the Chief Technology Officer at Aetion, where he leads Product, Engineering, Information Security, and Data Operations.

Tom serves as Aetion’s CFO. He brings deep expertise from his previous roles in both public and private equity owned companies.

Thomas “TJ” Carella serves as a Managing Director and Head of the Healthcare Group at Warburg Pincus, based in New York.

With more than a 20-year tenure investing in young and emerging healthcare technology companies, Bill Geary serves on boards of industry-leading companies, working closely with founders and management.

Dr. Scott Gottlieb is a Special Partner on the NEA healthcare investment team; he was a Venture Partner at NEA from 2007 to 2017 until being appointed the 23rd Commissioner of the U.S. Food and Drug Administration (FDA), where he served from 2017 to 2019.

Mohamad Makhzoumi first joined NEA in 2000 and now serves as Co-CEO of the firm. He was previously NEA’s Co-President, prior to which Mohamad served as Managing General Partner, Healthcare, where he led and oversaw NEA’s global healthcare investing practice across digital health and life sciences.

Tom is an Executive, Investor and Advisor for several innovative healthcare technology businesses across the payor and provider segments.

Cathy Polinsky is the Chief Technology Officer of DataGrail, an enterprise technology company that partners with brands on their data privacy journey to minimize risk, stay a step ahead of consumer and employee expectations, and save increasingly scarce resources. Previously she was Vice President of Engineering at Shopify.